HUMIRA® Subcutaneous Injection 40mg Syringe 0.8mL Now Available for the Treatment of Rheumatoid Arthritis
[ 2008/06/17 | Eisai Co., Ltd. | Pharmaceuticals | Tokyo | TSE1(PRIME) ]

The Company's Official Page
http://www.eisai.co.jp/enews/enews200836.html
Back To Previous Page
Dear User,
JPubb program could not collect the texts of this press-release from the official page, which perhaps mainly comprises tables, charts or images. Please refer to the official page indicated above. -- by JPubb

Latest News: Pharmaceuticals

    この内容でのリリース掲載はまだ無いか、集計されておりません。

more
    この内容でのリリース掲載はまだ無いか、集計されておりません。

more

Most Popular: Pharmaceuticals

1. Licensing Agreement for the Development,...
Kaken Pharmaceutical Co.,Ltd. 1970/01/01
2. Kaken Launches the Benzylamine Anti-tine...
Kaken Pharmaceutical Co.,Ltd. 1970/01/01
3. KAKEN PHARMACEUTICAL CO. and ELITRA PHAR...
Kaken Pharmaceutical Co.,Ltd. 2003/02/20
4. HUMIRA® received approval for the t...
Eisai Co., Ltd. 2008/04/16
5. Proton Pump Inhibitor ACIPHEX 20 mg Rece...
Eisai Co., Ltd. 2008/07/01

Latest News: Eisai Co., Ltd.


more

Most Popular: Eisai Co., Ltd.

1. Ajinomoto and Eisai Sign Agreement for D...
2009/02/10

Categories

Go to Page Top

View: Smartphone | PC

Language: English | Japanese

■Home

■Terms & Conditions

■Twitter ■Facebook

■About Us